Ten-Year Trends in Venous Thromboembolism Prophylaxis at a High-Volume Arthroplasty Center
In the past 10 years, our institution has transitioned from warfarin, UFH, and high-dose aspirin to low-dose aspirin and FXa, exhibiting acceptably low deep vein thrombosis and diminishing pulmonary embolism rates during that time.
Authors
- Colin M. Baker (ORCID: https://orcid.org/0000-0003-2333-1788)
- Matthew Sherman (ORCID: https://orcid.org/0000-0002-3258-3568)
- Yashas Reddy (ORCID: https://orcid.org/0000-0001-5314-863X)
- Matthew S. Austin (ORCID: https://orcid.org/0000-0002-4379-3392)
- Saad Tarabichi (ORCID: https://orcid.org/0000-0003-3866-4657)
- Juan D Lizcano (ORCID: https://orcid.org/0000-0002-8969-5341)
Institutions
- Rothman Institute (US)
- Object Research Systems (Canada) (CA)
Publication Details
- Journal
- Journal of the American Academy of Orthopaedic Surgeons
- Published
- 2024-10-17
- DOI
- https://doi.org/10.5435/jaaos-d-24-00507
- Citations
- 1
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.55